Screener
CorMedix CRMD Gross Profit
Discontinued — last reported Q1 '26
Gross Profit at other companies
Other financials
Where this comes from
Calculated from CorMedix’s reported figures.
The source filing: CorMedix’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 8:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001410098-26-000021
| Line item | For the Three Months Ended March 31, 2026 | For the Three Months Ended March 31, 2025 |
|---|---|---|
| Total Revenue | 127,427 | 39,082 |
| Cost of sales (exclusive of amortization of intangibles) | 12,005 | 1,545 |
| Amortization of intangibles | 10,300 | 52 |
| Gross profit | 105,122 | 37,485 |
| Operating Expenses: | ||
| Research and development | 7,212 | 3,193 |
| Selling and marketing | 12,532 | 4,474 |
| General and administrative | 21,720 | 9,693 |
Item 1. Unaudited Condensed Consolidated Financial Statements.
FAQ
- What is CorMedix's gross profit?
- CorMedix (CRMD) reported gross profit of $115.42M in Q1 2026.
- How has CorMedix's gross profit changed year-over-year?
- CorMedix's gross profit increased by 207.5% year-over-year, from $37.54M to $115.42M.
- What is the long-term trend for CorMedix's gross profit?
- Over 3 years (2021 to 2025), CorMedix's gross profit has grown at a 1803.3% compound annual growth rate (CAGR), from $42K to $289.57M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about CorMedix's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude